Tenofovir Disoproxil Fumarate/Emtricitabine/Elsulfavirine

N/A

Report date: 2025/03/19 16:22:32

Base Information

Drug NameTenofovir Disoproxil Fumarate/Emtricitabine/Elsulfavirine
Drug Alias NameVM-1500FDC
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitorsHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsHBV DNA Polymerase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseReverse transcriptaseHBV DNA Polymerase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes EmtricitabineElsulfavirineTenofovir Disoproxil Fumarate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesViriom Inc
China Registration ClassN/A

Develop Information

Active CompaniesViriom Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A